1-11 of 11
KAJSA KVIST
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes

BOCHRA ZAREINI, THOMAS A. GERDS, KATHRINE K. SØRENSEN, KIM K.B. CLEMMENSEN, KAJSA KVIST, JENS-PETER DAVID, CHRISTIAN TORP-PEDERSEN
Journal: Diabetes
Diabetes 2023;72(Supplement_1):201-LB
https://doi.org/10.2337/db23-201-LB
Published: 20 June 2023
View article titled, 201-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Renal Outcomes in Type 2 Diabetes
Meeting Abstracts

200-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Cardiovascular Outcomes in Type 2 Diabetes

BOCHRA ZAREINI, THOMAS A. GERDS, KATHRINE K. SØRENSEN, KIM K.B. CLEMMENSEN, KAJSA KVIST, JENS-PETER DAVID, CHRISTIAN TORP-PEDERSEN
Journal: Diabetes
Diabetes 2023;72(Supplement_1):200-LB
https://doi.org/10.2337/db23-200-LB
Published: 20 June 2023
View article titled, 200-LB: Benefit of Dual Therapy with GLP-1 RA and SGLT2i on Cardiovascular Outcomes in Type 2 Diabetes
Meeting Abstracts

65-LB: Real-World Continuous Glucose Monitoring Data on Time-in-Range from a U.S. Population, 2015–2019

RICHARD M. BERGENSTAL, ELISE HACHMANN-NIELSEN, JENS TARP, KAJSA KVIST, JOHN B. BUSE
Journal: Diabetes
Diabetes 2021;70(Supplement_1):65-LB
https://doi.org/10.2337/db21-65-LB
Published: 01 June 2021
View article titled, 65-LB: Real-World Continuous Glucose Monitoring Data on Time-in-Range from a U.S. Population, 2015–2019
Meeting Abstracts

21-LB: Derived Time-in-Range Is Associated with MACE in T2D: Data from the DEVOTE Trial

RICHARD M. BERGENSTAL, ELISE HACHMANN-NIELSEN, KAJSA KVIST, JOHN B. BUSE
Journal: Diabetes
Diabetes 2020;69(Supplement_1):21-LB
https://doi.org/10.2337/db20-21-LB
Published: 01 June 2020
View article titled, 21-LB: Derived Time-in-Range Is Associated with MACE in T2D: Data from the DEVOTE Trial
Meeting Abstracts

2160-PUB: Development of an Evidence-Based Tool to Facilitate Individualized Treatment in the Clinic for Patients with Type 2 Diabetes

ANNA R. KAHKOSKA, JOHN B. BUSE, SIGNE HARRING, INGRID HOLST, FILIP K. KNOP, KAJSA KVIST, RICHARD E. PRATLEY
Journal: Diabetes
Diabetes 2020;69(Supplement_1):2160-PUB
https://doi.org/10.2337/db20-2160-PUB
Published: 01 June 2020
View article titled, 2160-PUB: Development of an Evidence-Based Tool to Facilitate Individualized Treatment in the Clinic for Patients with Type 2 Diabetes
Meeting Abstracts

2187-PUB: Identifying Risk Predictors for Gastrointestinal Adverse Events with Once-Weekly Semaglutide

TINA VILSBØLL, SIGNE HARRING, INGRID HOLST, FILIP K. KNOP, KAJSA KVIST, ILDIKO LINGVAY
Journal: Diabetes
Diabetes 2020;69(Supplement_1):2187-PUB
https://doi.org/10.2337/db20-2187-PUB
Published: 01 June 2020
View article titled, 2187-PUB: Identifying Risk Predictors for Gastrointestinal Adverse Events with Once-Weekly Semaglutide
Meeting Abstracts

11-LB: Nonsevere Hypoglycemia Predicts Increased Risk of Subsequent Severe Events in Patients with Type 2 Diabetes

SIMON R. HELLER, ELISE HACHMANN-NIELSEN, KAJSA KVIST
Journal: Diabetes
Diabetes 2019;68(Supplement_1):11-LB
https://doi.org/10.2337/db19-11-LB
Published: 01 June 2019
View article titled, 11-LB: Nonsevere Hypoglycemia Predicts Increased Risk of Subsequent Severe Events in Patients with Type 2 Diabetes
Meeting Abstracts

8-LB: Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial

ANNA R. KAHKOSKA, ELISE HACHMANN-NIELSEN, KLARA KLEIN, KRISTINE G. KONGSBAK, KAJSA KVIST, JOHN B. BUSE
Journal: Diabetes
Diabetes 2019;68(Supplement_1):8-LB
https://doi.org/10.2337/db19-8-LB
Published: 01 June 2019
View article titled, 8-LB: Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial
Meeting Abstracts

89-LB: Low Level of Agreement in Evaluation of Continuous Glucose Monitoring Profiles

ELISE HACHMANN-NIELSEN, KAJSA KVIST, RICHARD M. BERGENSTAL
Journal: Diabetes
Diabetes 2019;68(Supplement_1):89-LB
https://doi.org/10.2337/db19-89-LB
Published: 01 June 2019
View article titled, 89-LB: Low Level of Agreement in Evaluation of Continuous Glucose Monitoring Profiles
Meeting Abstracts

15-LB: Diabetes Duration Did Not Moderate the Reduction in Severe Hypoglycemia Seen with Degludec vs. Glargine U100 in DEVOTE

ANASTASIA-STEFANIA ALEXOPOULOS, KAJSA KVIST, ELISE HACHMANN-NIELSEN, JOHN B. BUSE
Journal: Diabetes
Diabetes 2019;68(Supplement_1):15-LB
https://doi.org/10.2337/db19-15-LB
Published: 01 June 2019
View article titled, 15-LB: Diabetes Duration Did Not Moderate the Reduction in Severe Hypoglycemia Seen with Degludec vs. Glargine U100 in DEVOTE
Meeting Abstracts

Glycemic Variability Associated with Time Spent in Hypoglycemia in Type 1 Diabetes—Explorative Data in Real-World, Real-Time Continuous Glucose Monitoring

ELISE HACHMANN-NIELSEN, TRINE BARTHOLDY, CHRISTIAN BORN DJURHUUS, KAJSA KVIST
Journal: Diabetes
Diabetes 2018;67(Supplement_1):80-LB
https://doi.org/10.2337/db18-80-LB
Published: 01 July 2018
View article titled, Glycemic Variability Associated with Time Spent in Hypoglycemia in Type 1 Diabetes—Explorative Data in Real-World, Real-Time Continuous Glucose Monitoring